Final answer:
Carisoprodol products are listed as a Schedule IV controlled substance by the DEA, which indicates a lower potential for abuse compared to Schedule II substances like oxycodone and fentanyl.
Step-by-step explanation:
The Drug Enforcement Administration (DEA) has classified carisoprodol products as a Schedule IV controlled substance under the Controlled Substances Act. Substances in this schedule are considered to have a low potential for abuse relative to substances in Schedule III. However, they may lead to limited physical or psychological dependence. Schedule IV includes other drugs such as some benzodiazepines and sedatives. Carisoprodol is present in medications used for the relief of muscle pain and discomfort, but it can be associated with abuse and dependency issues if not used responsibly.
Among prescription pain relievers, carisoprodol's classification is less severe than Schedule II drugs which include substances like oxycodone, fentanyl, morphine, and methadone, all of which have a higher potential for abuse and dependence. It should be used cautiously, following a doctor's prescription and guidelines. Medications under Schedule II include well-known pain medications such as Vicodin and Percocet.